-
The Game Has Changed
Blogs
A lot has changed in medtech since the 1980s, but many medtech companies’ commercial models have yet to adapt.
-
Have We Reached the Medtech ‘Tipping Point’?
Article
Changes in the medtech industry have resulted in new buyer behavior, sales strategies and sales resource requirements. ZS recommends four steps to adapt your sales compensation program to support growth and retain talent in this new environment.
-
-
-
Sales Comp Checklist? Check.
Blogs
Creating a detailed checklist and following it carefully will prevent errors within your sales incentive plan. Here's how to create your own checklist.
-
Pick Up the Pace on Patient Centricity
Article
The goal of every life sciences company is to help patients, but many companies struggle with a patient-centric strategy especially when it comes to drug development. Read this article to learn how a patient-centered approach can alter clinical trials and the four pillars you need to incorporate today.
-
-
-
The New Oncology Launch Environment
Blogs
To succeed in today’s crowded oncology space, pharmaceutical companies must rethink their go-to-market strategies. Here’s why you should “always be launching.”
-
Always Be Launching
Whitepaper
As the commercial viability of cancer drugs increasingly relies on approval in multiple settings, it becomes more important than ever to develop a more “continuous” launch model, write Sarah Hamilton and Dave Cohen.
-
-
-
Working Toward a Healthy Prognosis
Article
Amy Marta outlines how marketing research could tranform in the coming years in response to the ever-changing health care industry.
-
Showdown at the ‘IO’ Corral
Blogs
In immunotherapy, CAR-Ts and CPIs have had complementary but distinct roles. As they start to enter each other’s spaces, where will companies place their bets?
-
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
Displaying 361 - 375 of 860